12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Immunogen (IMGN) saw an 83.0% increase to $29.39 with a market cap of $7.8 billion. Ampio Pharmaceuticals (AMPE) rose by 65.82% to $3.25, Aditxt (ADTX) by 65.71% to $5.8, Soligenix (SNGX) by 40.27% to $0.58, Sutro Biopharma (STRO) by 19.04% to $2.75, and China SXT Pharmaceuticals (SXTC) by 14.99% to $2.07. Conversely, Vivos Therapeutics (VVOS) dropped by 35.6% to $26.4, Redhill Biopharma (RDHL) by 26.39% to $2.12, Conduit Pharmaceuticals (CDT) by 15.3% to $4.32, ProSomnus (OSA) by 14.89% to $0.8, Alzamend Neuro (ALZN) by 14.26% to $1.0, and Pasithea Therapeutics (KTTA) by 13.79% to $0.31.

November 30, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ampio Pharmaceuticals stock increased by 65.82% to $3.25, with a market cap of $2.7 million.
Ampio Pharmaceuticals' substantial pre-market rise indicates a positive development for the company, potentially driving the stock price up in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Immunogen shares surged by 83.0% to $29.39 in pre-market trading with a market cap of $7.8 billion.
The significant pre-market surge in Immunogen's stock price suggests positive investor sentiment or reaction to recent company news, which could lead to a short-term upward trend in the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Redhill Biopharma stock decreased by 26.39% to $2.12, with a market cap of $23.4 million.
The pre-market decline in Redhill Biopharma's stock price could reflect adverse events or market reactions, likely resulting in a negative short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Vivos Therapeutics shares fell by 35.6% to $26.4, with a market cap of $31.6 million.
The sharp decline in Vivos Therapeutics' stock price during pre-market suggests negative news or investor sentiment, which could lead to a short-term downtrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100